IPSS-M improved prognostic discrimination across all clinical end points with respect to IPSS-R (concordance was 0.81 v 0.74 for overall survival and 0.89 v 0.76 for leukemia-free survival, ...
SAN ANTONIO, October 14, 2025--(BUSINESS WIRE)--Wytec International, Inc. ("Wytec" or the "Company"), a leader in smart-city and wireless innovation, today announced the launch of its Integrated ...
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study The IPSS-M provides important new ...
Implementing the International Prognostic Scoring System-Molecular (IPSS-M) in clinical practice could impact clinical management for nearly half of patients with myelodysplastic syndromes (MDS), ...
A well-regarded tool for predicting prognosis in myelodysplastic syndromes is updated to incorporate mutations and tested with real-world data. An abstract and poster presented at the 2023 American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results